Acurx Pharmaceuticals (ACXP) Earnings Date & Reports

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACXP is expected to report earnings to fall 14.71% to -14 cents per share on March 13

Acurx Pharmaceuticals ACXP Stock Earnings Reports

Q4'24

Est.

$-0.14

Q3'24

Missed

by $0.02

Q2'24

Missed

by $0.09

Q1'24

Missed

by $0.04

Q4'23

Missed

by $0.12

The last earnings report on November 13 showed earnings per share of -17 cents, missing the estimate of -15 cents. With 60.08K shares outstanding, the current market capitalization sits at 8.60M.

View a ticker or compare two or three

Compare

ACXP